1. Home
  2. TKLF vs BRTX Comparison

TKLF vs BRTX Comparison

Compare TKLF & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TKLF

Yoshitsu Co. Ltd

HOLD

Current Price

$1.81

Market Cap

8.3M

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.21

Market Cap

7.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
BRTX
Founded
2006
1997
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
7.1M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
TKLF
BRTX
Price
$1.81
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.5K
337.4K
Earning Date
12-19-2025
05-13-2026
Dividend Yield
10.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
$2.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$0.16
52 Week High
$4.32
$1.89

Technical Indicators

Market Signals
Indicator
TKLF
BRTX
Relative Strength Index (RSI) 42.79 28.57
Support Level $1.78 $0.21
Resistance Level $2.43 $0.28
Average True Range (ATR) 0.10 0.03
MACD -0.02 -0.01
Stochastic Oscillator 37.44 10.91

Price Performance

Historical Comparison
TKLF
BRTX

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: